![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.395 | -8.31% | 4.36 | 4.35 | 4.69 | 4.75 | 4.36 | 4.75 | 212,429 | 16:09:36 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.50 | 9.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/5/2020 20:40 | Ah well hope Jackie in accounts had a nice birthday anyway 😉 | ![]() adman50 | |
14/5/2020 20:10 | Peachy you're right! The nebuliser for me will occupy a niche that seems to have little competition ATM. And plenty of people will be trying to boost their antibodies to help all sorts of ailments. And that means lots of sales!! | ![]() macmuck | |
14/5/2020 19:58 | Could this hit 300 pence on positive results ? Guy in Bradford saying he's certain. | ![]() amaretto1 | |
14/5/2020 19:22 | An excellent new paper summarising interferons and their impact on Coronaviruses to be published in the June Antiviral Research volume. Have you seen this before @Nobbygnome? Lots of positives for SNG, e.g. “Consequently, IFNβ1 appears to be most relevant interferon to treat coronavirus infections. This fact can be related to the protective activity of IFNβ1 in the lung: it up-regulates cluster of differentiation 73 (CD73) in pulmonary endothelial cells, resulting in the secretion of anti-inflammatory adenosine and the maintenance of endothelial barrier function.“ & “The administration by vapor inhalation currently performed in China offers the advantage of targeting specifically the respiratory tract; however, to the best of our knowledge, the pharmacodynamics and pharmacokinetics of this mode of administration have never been assessed. On the contrary, the intravenous and subcutaneous modes of administration are well-described, have already proven safe in several clinical trials, and have similar pharmacodynamics and pharmacokinetics (Mager and Jusko, 2002).” | ![]() 74tom | |
14/5/2020 18:44 | NHS England has just published a breakdown of the illnesses which people have when they die with COVID. Interestingly almost a quarter are COPD/Asthma patients which we know can benefit from SNG. | ![]() pdt | |
14/5/2020 17:04 | Everybody knows we have to wait till June for anything definitive so which don't we just close shop here till then?! | ![]() hazl | |
14/5/2020 16:58 | You might be waiting a long time IMO | ![]() crookie3634 | |
14/5/2020 16:57 | My logic is I live with the fairy’s | ![]() crookie3634 | |
14/5/2020 16:56 | Volsung If the placing took place last week then maybe yes it could return to 40p but since the placing, a distressed seller has continued to sell millions of shares and the share price remains stagnant. Thats a fantastic result thus far. The selling has been done in order to protect the share price so with all due respect i can't see the share price go that low until after the trials(subject to poor results which we are not expecting). | sgn001 | |
14/5/2020 16:56 | I had a chat with my mate yesterday and he said this will hit £50 so I might fill my boots | ![]() crookie3634 | |
14/5/2020 16:56 | (Drew )just in case I get pulled up again | ![]() best1467 | |
14/5/2020 16:55 | Volsung 40p?? Please provide your logic? | ![]() crookie3634 | |
14/5/2020 16:55 | Vulsong Would you like to share your analysing which draw the conclusion it’s heading for 40p as I was looking to add in the low 50p range | ![]() best1467 | |
14/5/2020 16:30 | I'm not so worried about Lansdowne particularly - it's the ex- Woody holding which is the concern for me. | ![]() toffeeman | |
14/5/2020 16:24 | I was analysing this last night while watching Lykkeland. I think its good right but the price is a wee bit too high ergo the price will go down to 40p. I verified my reasoning with my mate and he agreed with me. Thus I believe strongly this security will go down to 40p | ![]() volsung | |
14/5/2020 16:18 | tburns, Perhaps surprising, but there’s no official evidence Link are selling. Just Lansdowne, possibly trying to cover losses elsewhere in their Funds. | ![]() wetdream | |
14/5/2020 16:15 | Is that a subtle deramp?We should get news on last person dosed shortly | ![]() dave444 | |
14/5/2020 16:11 | So on the basis that Lansdowne & Link are still dumping and no reason to see why not then we have at least another day of drip drip to come it seems WD | ![]() tburns | |
14/5/2020 16:03 | Imho the bulk of the stock we may see late reported today will have been traded yesterday, so we’re generally a day behind the real action. | ![]() wetdream | |
14/5/2020 15:58 | The fact that we seem to have lines of buys and yet the price still falls gives the impression that more stock will be shown as dumped after hours. Feels like bloody groundhog day everytime you wake up at present. I just hope we manage to stay above 50p over the next few trading days with no update expected for another 3 or so weeks | ![]() tburns | |
14/5/2020 14:35 | Might it not be a stand-off... Seller won’t drop his price; so buyers wait. Perhaps the sellers and buyers were one and the same-under the BEGO/Peel umbrella? | ![]() wetdream | |
14/5/2020 14:21 | It would seem the seller has stopped. Ironically, when they were selling there were loads of buyers. Now the majority of the buyers have disappeared hence the malaise in the share price All things being equal it has held up pretty well today against the wider market and sentiment that is prevailing today. | ![]() vitec | |
14/5/2020 14:13 | Yep agreed | ![]() chinadog3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions